Related Experiment Videos
Delayed endolymphatic hydrops
The Annals of Otology, Rhinology, and Laryngology
|November 1, 1978
Summary
Delayed endolymphatic hydrops (DEH) is distinct from Ménière's disease. DEH presents with vertigo or hearing loss in one or both ears after prior profound hearing loss, with limited treatment options for the contralateral form.
Area of Science:
- Otolaryngology
- Neurology
- Audiology
Background:
- Delayed endolymphatic hydrops (DEH) is a distinct clinical entity.
- It typically follows profound unilateral hearing loss from causes like infection or trauma.
- DEH differs from Ménière's disease in its etiology and presentation.
Observation:
- DEH manifests in two forms: ipsilateral and contralateral.
- Ipsilateral DEH involves episodic vertigo originating from the previously affected ear.
- Contralateral DEH presents with fluctuating hearing loss and sometimes vertigo in the opposite ear.
Findings:
- The ipsilateral form of DEH can be managed with labyrinthectomy.
- Currently, no effective therapeutic options exist for the contralateral form of DEH.
- This highlights a significant unmet need in treating contralateral DEH.
Implications:
- Distinguishing DEH from Ménière's disease is crucial for appropriate patient management.
- Further research is needed to develop treatments for contralateral DEH.
- Understanding DEH pathophysiology may lead to novel therapeutic strategies for inner ear disorders.